1.41 pm | 14 Jun 2013 |  Source: Moneycontrol.com

The US FDA import alert means US authorities can detain without physical examination of new drugs promoted in the US. Dabur, however, says it doesn't ...

3.22 pm | 12 Jun 2013 |  Source: CNBC-TV18

Prashant Nair of Citi India told CNBC-TV18 that the pharma sector's valuations in current market downturn situation has held up well. He presents his ...

8.04 pm | 10 Jun 2013 |  Source: CNBC-TV18

Dipan Mehta, member, BSE & NSE says, in an interview to CNBC-TV18, that the market will shift focus from rate-sensitives to exports and advises invest...

6.08 pm | 10 Jun 2013 |  Source: CNBC-TV18

Dipan Mehta is overweight on IT sector with rupee depreciating. Among the pharma stocks, he likes Sun Pharma, Dr Reddy's, Wockhardt and Cadila. ...

1.44 pm | 08 Jun 2013 |  Source: Moneycontrol.com

Ventura has recommended hold rating on Wockhardt, in its May 29, 2013 research report. According to the research firm, in the short term the stock wil...

4.00 pm | 04 Jun 2013 |  Source: Moneycontrol.com

FinQuest Securities is bullish on Wockhardt (WPL) and has recommended buy rating on the stock with a target price of Rs 1,450 in its May 31, 2013 rese...

7.36 pm | 03 Jun 2013 |  Source: CNBC-TV18

CNBC-TV18's Rituparna Bhuyan reports that the Indian government today came out in defence of the Indian pharma sector. A release by commerce ministry ...

4.34 pm | 31 May 2013 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com feels Wockhardt may test Rs 1,300 in one year timeframe. However, short term investor should exit the stock....

3.42 pm | 29 May 2013 |  Source: CNBC-TV18

Dr Reddy’s Laboratory and Lupin are top picks of Nomura India's Saion Mukherjee. He expects Sun Pharma to come off from current highs and see operat...

5.50 pm | 27 May 2013 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com advises to buy Wockhardt with deep stop loss....

2.40 pm | 27 May 2013 |  Source: Moneycontrol.com

Wockhardt reported an exceptional loss of Rs 10.7 crore during the March quarter, compared to a similar outgo of Rs 396 crore last year same period. ...

2.13 pm | 27 May 2013 |  Source: CNBC-TV18

Rajen Shah, CIO at Angel Broking is of the view that one can see modest upside in Wockhardt. "At this level it is trading at just about 10 times the c...

2.05 pm | 27 May 2013 |  Source: CNBC-TV18

SP Tulsian of sptulsian.com is bullish on Britannia Industries and recommends buying the stock with a day target of Rs 609 and stop loss of Rs 569....

10.46 am | 27 May 2013 |  Source: CNBC-TV18

Rajen Shah is positive on L&T, Crompton Greaves, Jet Airways, but advises investors to stay away from commodity related stocks like Tata Steel....

9.53 am | 27 May 2013 |  Source: CNBC-TV18

Meanwhile, the US Food and Drug Administration issues which have been haunting various pharma players for a while now, are company specific and won't ...

9.17 am | 27 May 2013 |  Source: CNBC-TV18

Saurabh Mittal of Swadeshi Capital advised buying YES Bank with a target price of Rs 515. Meanwhile, Nooresh Merani of AMSEC Research advised buying D...

4.02 pm | 25 May 2013 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com advised short-term traders to go long in Wockhardt with a stoploss. He feels the uptrend in the stock is intact....

3.58 pm | 25 May 2013 |  Source: CNBC-TV18

SP Tulsian of sptulsian.com says he is positive on Sun Pharma as well as Wockhardt, but he will prefer the latter one for short term....

1.44 pm | 25 May 2013 |  Source: CNBC-TV18

SP Tulsian, sptulsian.com believes that one has to look for the global cues. "There are indications we keep getting, if it will affect market expiry,"...

12.48 pm | 25 May 2013 |  Source: CNBC-TV18

In an interview to CNBC-TV18, technical analyst Sudarshan Sukhani of s2analytics.com says he is watching the 5970 level very carefully right now....